Hemorrhage Prevention Compounds Patent Application
Summary
Jesus E. VILLAFRANCA, Charles Richard KISSINGER, and Guohong LI filed Application US20260108481A1 on December 12, 2025, for compounds and methods for the prevention and treatment of hemorrhage and vascular instability. The application, which relates to therapeutic compounds potentially induced by thrombolytic and anti-coagulant therapies, was published on April 23, 2026. The invention is classified under CPC codes including A61K 31/167, A61K 38/482, and A61P 7/04.
“Hemorrhage and vascular instability can be induced by thrombolytic and anti-coagulant therapies.”
About this source
GovPing monitors USPTO Patent Applications - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 193 changes logged to date.
What changed
The USPTO published Application US20260108481A1 for compounds and methods of treating hemorrhage and vascular instability. The application names Jesus E. VILLAFRANCA, Charles Richard KISSINGER, and Guohong LI as inventors, with a filing date of December 12, 2025. The published application includes an abstract describing therapeutic methods using the disclosed compounds for subjects in need thereof.
Pharmaceutical manufacturers and drug developers researching hemostatic agents or anti-coagulant reversal therapies may wish to review this published application to assess potential freedom-to-operate considerations or identify potential licensing opportunities. Published patent applications serve as prior art as of the filing date, which may be relevant for competitive intelligence and IP strategy purposes.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOUNDS FOR PREVENTION AND TREATMENT OF HEMORRHAGE AND VASCULATURE INSTABILITY
Application US20260108481A1 Kind: A1 Apr 23, 2026
Inventors
Jesus E. VILLAFRANCA, Charles Richard KISSINGER, Guohong LI
Abstract
Hemorrhage and vascular instability can be induced by thrombolytic and anti-coagulant therapies. Presented herein, in certain aspects, are methods for the treatment and/or prevention of hemorrhage and vascular instability that comprise administering a compound disclosed herein to a subject in need thereof.
CPC Classifications
A61K 31/167 A61K 38/482 A61P 7/04 A61P 9/10 C12Y 304/21068
Filing Date
2025-12-12
Application No.
19418727
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.